Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
- Electrolyte and Acid–Base Disturbances in Patients with Diabetes MellitusNew England Journal of Medicine, Volume 381, Issue 16, Page 1598-1598, October 2019.
- Randomized Trial of Medical versus Surgical Treatment for Refractory HeartburnNew England Journal of Medicine, Volume 381, Issue 16, Page 1513-1523, October 2019.
- Unplugging the Pipeline — A Call for Term Limits in Academic MedicineNew England Journal of Medicine, Volume 381, Issue 16, Page 1508-1511, October 2019.
- 20-Year Follow-up of Statins in Children with Familial HypercholesterolemiaNew England Journal of Medicine, Volume 381, Issue 16, Page 1547-1556, October 2019.
- Democratizing Evidence Production — A 51-Year-Old Man with Sudden Onset of Dense HemiparesisNew England Journal of Medicine, Volume 381, Issue 16, Page 1501-1505, October 2019.
- Case 32-2019: A 70-Year-Old Woman with Rapidly Progressive AtaxiaNew England Journal of Medicine, Volume 381, Issue 16, Page 1569-1578, October 2019.
- More about Factor H Autoantibodies in Membranous NephropathyNew England Journal of Medicine, Volume 381, Issue 16, Page 1590-1592, October 2019.
- Erdafitinib in Urothelial CarcinomaNew England Journal of Medicine, Volume 381, Issue 16, Page 1593-1595, October 2019.
- Preexisting ConditionsNew England Journal of Medicine, Volume 381, Issue 16, Page 1586-1589, October 2019.
- New Guidelines for Statistical ReportingNew England Journal of Medicine, Volume 381, Issue 16, Page 1597-1598, October 2019.
- Calcinosis in Juvenile DermatomyositisNew England Journal of Medicine, Volume 381, Issue 16, October 2019.
- The Cost of Applying to Medical School — A Barrier to Diversifying the ProfessionNew England Journal of Medicine, Volume 381, Issue 16, Page 1505-1508, October 2019.
- Atrophic GlossitisNew England Journal of Medicine, Volume 381, Issue 16, Page 1568-1568, October 2019.
- Ribociclib and Endocrine Therapy in Breast CancerNew England Journal of Medicine, Volume 381, Issue 16, Page 1592-1593, October 2019.
- Lipid Management for the Prevention of Atherosclerotic Cardiovascular DiseaseNew England Journal of Medicine, Volume 381, Issue 16, Page 1557-1567, October 2019.
- Think First, Cut Last — Lessons from a Clinical Trial of Refractory HeartburnNew England Journal of Medicine, Volume 381, Issue 16, Page 1580-1582, October 2019.
- Nintedanib for Systemic Sclerosis–Associated Interstitial Lung DiseaseNew England Journal of Medicine, Volume 381, Issue 16, Page 1595-1597, October 2019.
- Ticagrelor or Prasugrel in Acute Coronary Syndromes — The Winner Takes It All?New England Journal of Medicine, Volume 381, Issue 16, Page 1582-1585, October 2019.
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 DiabetesNew England Journal of Medicine, Ahead of Print.
- Toward Automated Insulin DeliveryNew England Journal of Medicine, Ahead of Print.
- Will Emergency Holds Reduce Opioid Overdose Deaths?New England Journal of Medicine, Ahead of Print.
- Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery DiseaseNew England Journal of Medicine, Ahead of Print.
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 DiabetesDespite advances in care, attaining good glycemic outcomes in patients with type 1 diabetes remains challenging; the targets set by the American Diabetes Association are met in only a minority of patients. The use of a closed-loop system (also referred to as an "artificial pancreas") that automates…
- More about Factor H Autoantibodies in Membranous NephropathyTo the Editor: Primary membranous nephropathy, one of the most common causes of nephrotic syndrome in adults, results from the deposition of IgG and complement components in the subepithelial layer of the glomerular basement membrane. In 70 to 80% of patients with this condition, antibodies that…
- Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesAccording to the American Heart Association, approximately 720,000 persons in the United States will have a first episode of an acute coronary syndrome and approximately 335,000 will have a recurrent coronary event in 2019. Dual antiplatelet therapy (an adenosine diphosphate receptor antagonist and…
- Ticagrelor or Prasugrel in Acute Coronary Syndromes — The Winner Takes It All?Orville Wright said, "If we all worked on the assumption that what is accepted as true is really true, there would be little hope of advance." Approximately one person in the United States has a myocardial infarction every 40 seconds, and more than 1 million coronary events occur each year, of…
- Will Emergency Holds Reduce Opioid Overdose Deaths?The opioid overdose crisis has claimed more than 400,000 lives in the United States since 1999. As part of efforts to reduce overdose deaths and increase enrollment in treatment, lawmakers in some states are contemplating enacting or expanding emergency hold laws that permit some patients with…
- Toward Automated Insulin DeliveryFor patients with type 1 diabetes, achieving the glycemic target recommended by the American Diabetes Association remains challenging, despite the use of insulin pumps, sensors for continuous glucose monitoring, the combination of these technologies (sensor-augmented pump), and systems that…
- Think First, Cut Last — Lessons from a Clinical Trial of Refractory HeartburnConceptualizing gastroesophageal reflux disease (GERD) as a single disease process that will respond to higher and higher doses of acid suppression is a mistake. The underlying mechanisms that can lead to reflux of stomach contents into the esophagus and subsequent symptoms or esophagitis are…
- Randomized Trial of Medical versus Surgical Treatment for Refractory HeartburnIn the United States, approximately 20% of adults regularly have symptoms of gastroesophageal reflux disease (GERD), and annual costs for managing GERD exceed $12 billion. Patients with heartburn, the cardinal symptom of GERD, report reduced work productivity and significant impairments in…
- Preexisting ConditionsDoc gets these calls more often now, cries for help from family and friends. They call him, he says, because he’s the one doctor they know who answers the phone himself (he’s retired) — none of that "please listen carefully, our menu has changed." Often the calls come from a distance, like when his…
- Democratizing Evidence Production — A 51-Year-Old Man with Sudden Onset of Dense HemiparesisIn 2015, a 51-year-old farmer, Mr. K. arrived at the Jan Swasthya Sahyog hospital — an approximately 100-bed hospital in an underserved part of rural central India that provides care to a population of 1.5 million, mostly from poor, marginalized indigenous communities. Mr. K. presented with a…
- Lipid Management for the Prevention of Atherosclerotic Cardiovascular DiseaseIn 1961, the investigators involved in the Framingham Heart Study identified serum cholesterol as one of the "factors of risk" for coronary heart disease. Since then, numerous epidemiologic studies and randomized clinical trials have established that an elevated level of low-density lipoprotein…
- Case 32-2019: A 70-Year-Old Woman with Rapidly Progressive AtaxiaPresentation of Case. Dr. Kun-Wei Song (Neurology): A 70-year-old woman was admitted to this hospital because of rapidly progressive ataxia. The patient had been in her usual state of good health until 3 months before this admission, when fatigue and general unsteadiness developed. Two months…
Πέμπτη 17 Οκτωβρίου 2019
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου